Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

Food for thought for all those who think a buyout price in the range of $20 to $25 is way too low: which of the following two scenarios would you rather see:

1) Cash buyout of the company in the coming weeks or months in the range of $20 to $25 from an entity like Amgen who will be able to take the platform to market faster and exchange your shares with cash at a nice premium so that you will never have to worry about short manipulation, poor management of the company, another clinical hold, etc.

2) Another massive dilution that pushes the stock price down even lower than the level we are at (and the current stock level ALREADY represents 40% shareholder value destroyed over the last four years under O'Connor) at a time when the broad market is at an all time high and the bull market is getting long in the tooth?

I vote for option #1 and encourage everyone to express their view to the company and Board of Directors before we get "hit" again.